Thursday, November 14, 2024 at 12-1pm ET                             Open to AMCP Members Only (Free)

Please note that this session is not accredited for continuing pharmacy education credit.

Program Description

In this one-hour webinar we will dive deep into CMS' recently finalized negotiation guidance for Initial Price Applicability Year (IPAY) 2027, exploring how CMS has proposed to modify the negotiation program in its second year. We will also explore how manufacturers of drugs selected for both IPAY 2026 and 2027 will make their drugs available to Medicare beneficiaries and dispensing entities at the negotiated maximum fair price, including through two separate functions provided by a Medicare Transaction Facilitator (MTF). Lastly, we will touch briefly on recent litigation developments challenging the negotiation program.

Learning Objectives

• Understand the current status of the Medicare Drug Price Negotiation Program.
• Gain clarity on how CMS has proposed to modify the program in its second year.
• Explore the role of the Medicare Transaction Facilitator in making the maximum fair price available to beneficiaries in 2026 and beyond.